Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 22;7(3):e44732.
doi: 10.5812/aapm.44732. eCollection 2017 Jun.

The Efficacy of Systemic Lidocaine in the Management of Chronic Pain: A Literature Review

Affiliations
Review

The Efficacy of Systemic Lidocaine in the Management of Chronic Pain: A Literature Review

Fardin Yousefshahi et al. Anesth Pain Med. .

Abstract

Context: Despite recent advances in the understanding of the chronic pain concept, its diagnosis and management remains a daily challenge for clinicians and patients. Based on the published literature, this review discusses and tries to organize the current knowledge and the up-to-date clinical experience about the efficacy and safety of the use of intravenous lidocaine in treatment and prevention of chronic pain.

Evidence acquisition: To prepare this narrative review, we performed an in depth literature review using the PubMed searching engine. We extracted all relevant articles published in English, up to April 2016.

Results: Lidocaine, administered as transdermal patch or intravenous lidocaine, is a safe and effective modality in the treatment of post-herpetic neuralgia (PHN), complex regional pain syndrome, as well and for prevention of chronic pain. It may be effective in the management of neuropathic pain syndromes, chronic pain, post-operative pain, and refractory cancer pain.

Conclusions: Intravenous lidocaine and lidocaine patch are effective and safe for the treatment of several chronic or neuropathic pain syndromes. The use of lidocaine during surgery could prevent the development of some chronic post-surgical pain syndromes.

Keywords: Chronic Pain; Complex Regional Pain Syndrome; Lidocaine; Neuropathic Pain; Post-Herpetic Neuralgia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest:There is no conflict of interest for this study.

References

    1. Gilron I, Jensen MP. Clinical trial methodology of pain treatment studies: selection and measurement of self-report primary outcomes for efficacy. Reg Anesth Pain Med. 2011;36(4):374–81. doi: 10.1097/AAP.0b013e318217a635. - DOI - PubMed
    1. Voscopoulos C, Lema M. When does acute pain become chronic? Br J Anaesth. 2010;105 Suppl 1:i69–85. doi: 10.1093/bja/aeq323. - DOI - PubMed
    1. Mifflin KA, Kerr BJ. The transition from acute to chronic pain: understanding how different biological systems interact. Can J Anaesth. 2014;61(2):112–22. doi: 10.1007/s12630-013-0087-4. - DOI - PubMed
    1. Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol. 2010;229(1-2):26–50. doi: 10.1016/j.jneuroim.2010.08.013. - DOI - PubMed
    1. Calvo M, Dawes JM, Bennett DL. The role of the immune system in the generation of neuropathic pain. Lancet Neurol. 2012;11(7):629–42. doi: 10.1016/S1474-4422(12)70134-5. - DOI - PubMed